NCT02196363

Brief Summary

Babies that are either very small or very big have increased perinatal morbidity and mortality. Predicting which babies will fall into these groups is traditionally done with risk assessment and third trimester manual palpation, however neither of these techniques are sensitive and a considerable number of affected pregnancies are missed. This results in stillbirth for small babies or birth trauma for larger ones. Serial scanning in the third trimester can improve detection rates but this is expensive and cannot currently be provided to all NHS patients. A more sensitive test that can be performed earlier in pregnancy would allow identification of at risk pregnancies allowing for increased monitoring. New three dimensional ultrasound techniques that measure volume and volumetric flow have become available that may allow this to happen. This study proposes to trial newer ultrasound techniques on a cohort of pregnant women. The findings from these scans will then be correlated with actual birth weights at the end of pregnancy to determine the ability of these parameters to act as screening tools for babies at the extremes of size.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
253

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2010

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2010

Completed
4 years until next milestone

First Submitted

Initial submission to the registry

July 16, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 22, 2014

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2015

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
Last Updated

December 4, 2018

Status Verified

November 1, 2018

Enrollment Period

4.6 years

First QC Date

July 16, 2014

Last Update Submit

November 30, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Kidney volume, thigh volume, placental volume, brain volume, final birthweight

    up to 34-36 weeks pregnancy gestation

Study Arms (1)

Pregnant mothers

No intervention

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants will be identified by screening booked scan appointments in regular antenatal clinics. The first approach will be by either the named local investigators

You may qualify if:

  • Pregnant women the beginning of pregnancy to term

You may not qualify if:

  • Pregnancies in women previously affected by unclassfied fetal abnormality
  • Multiple pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Central Manchester University Hospitals NHS Foundation Trust

Manchester, M13 9WL, United Kingdom

Location

Study Officials

  • Ed Johnstone, MBChB PhD MRCOG

    CMFT

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 16, 2014

First Posted

July 22, 2014

Study Start

July 1, 2010

Primary Completion

February 1, 2015

Study Completion

July 1, 2015

Last Updated

December 4, 2018

Record last verified: 2018-11

Locations